CATHERINE GARFUNKEL: Open Payments
NPI 1275155517 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 74 payments from 20 companies in 2025. Trend: 2023 $1,345 · 2024 $1,653 · 2025 $1,611
Food & beverage: $1,506Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $405 |
| Janssen Biotech, Inc. | 11 | $322 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $146 |
| GENZYME CORPORATION | 3 | $105 |
| Phathom Pharmaceuticals, Inc. | 8 | $100 |
| Ardelyx, Inc. | 4 | $91 |
| PFIZER INC. | 3 | $63 |
| QOL Medical, LLC | 2 | $60 |
| Gilead Sciences, Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
Products named: TREMFYA, LINZESS, XIFAXAN, DUPIXENT, SKYRIZI, RINVOQ, VOQUEZNA, IBSRELA.
Industry payments across GA — which companies pay providers there.
